Clinical Trial Search

Primary: Percent Change in Plasma Triglycerides — -2.0; 16.0; -5.0; -5.0 percent change

Primary: Age and Sex-Standardized Incidence Rates for the 10 Most Common Cancers Stratified by Diabetes Status — 380.2; 421.9; 308.0; 281.9 Incidence per 100,000 person-years

Primary: Disposition Index — 0.023; 0.149 index

Primary: Fasting Plasma Glucose <126 mg/dL and HbA1c < 6.5% at Three Years of Follow-up. — 13; 5; 42; 0 % of patients — p=0.60

Primary: The Percentage Change in HbA1c Level From Baseline to 12 Weeks — -11.1; 0.0 percentage change

Primary: Change in Weight From Baseline at 12 Months or More — -8.37 Kg — p=<0.05

Primary: Beta-cell Function - C-peptide AUC (Area Under the Curve) — 2096; 1725 ng*min/mL

Primary: Weight — 103.8; 100.7 kg — p=0.44

Primary: Diabetes Remission Rate — 3; 6 Participants — p=<0.0001

Primary: Δ Mean AUC (Area Under the Curve) Plasma [Glucose] — -17.7; 54.9 mmol.min.L-1

Primary: Frequency of Eating in Response to Cravings (Primary Mechanistic Outcome) — -20.39; -25.27 % of EMAs with craving related eating

Primary: Abnormal Glucose Levels After Colonoscopic Preparation — 2; 0; 185 Participants

Primary: Change in Hemoglobin A1c — -0.37; -0.15; -0.31; -0.20 percentage of glycated hemoglobin

Primary: Difference in Insulin Resistance (HOMA) Between Treatments After 12 Weeks of Product Intake — 2.82; 2.21; 2.75 HOMA index

Primary: HbA1c Level — 6.9; 6.4 percentage of glycated hemoglobin

Primary: Percentage of Patients With Type 2 Diabetes Mellitus Who Achieve Fasting Blood Glucose of Less Than 5.6 mmol/l and/or HbA1c of Less Than 6% — 4; 4 Participants

Primary: Change in Fasting Insulin Level — -2.47; -0.08; -1.16; 2.79 mU/L — p=<0.0001

Primary: Change (From Baseline) in Self-reported Intake (Servings/Day) of Sugar-sweetened Beverages (Measured Using the Nutrition Assessment Shared Resource Food Frequency…

Primary: Number of Children With Documented Risk Factors for Type 2 Diabetes — 283; 282 Participants

Primary: Body Mass Index (BMI) - Post-Test — 30.3; 28.8 kg/m2

Primary: Calories Purchased — 24443.30; 25339.20; 18527.35 Kcal

Primary: Glycosylated Hemoglobin Change — 6.82; 7.17; 6.80; 6.33 percentage of glycosylated hemoglobin — p=0.830

Primary: Neuropathic Pain — 482; 461; 560 Participants

Primary: Change in Breast Density at 6 Months — -5.45; -13.71 cm^3

Primary: Change in Energy Intake From Baseline — 500; 310; 482; 5 kcal

Primary: Total Physical Activity Log Means and Geometric Means With Standard Deviation in Intervention and Control Groups After Intervention. — 216.07; 201.47 log calories/day…

Primary: Incident Diagnosis of Bladder Cancer (10-year Analysis) — 89.8; 75.9 events per 100,000 person years

Primary: Blood Pressure — 125.6; 126.0; 74.6; 75.1 mm Hg — p=0.56

Primary: Chang in Disposition Index, a Measure of Beta Cell Function — 287; 314; -122; -129 units on a scale

Primary: Change in Glycemic Measures- HbA1c (12w) — -0.22; -0.25 percentage of glycated hemoglobin